Maintain OVERWEIGHT on CL with refined tiered execution—smaller Tier 1 with confirmation filters to resolve asymmetry math problem
Overweight is correct because the structural bull thesis is too durable to fade, but asymmetry math and broken technicals preclude "strong conviction" Buy rating. The $85.99 stop is held as it sits 60 cents above the 200 SMA (rising from $83.41 to $86.41 over eight weeks), providing genuine technical defense. The 22x forward P/E sits at upper end of CL's 18-20x historical band—fair, not cheap. Conservative's $87.50 stop is incoherent (stopping out 60 cents above own high-conviction zone). The 8/24 and 8/21 reflections resolve correctly: defensive flows prevent breakdowns in quality compounders, but buying at $91 into fresh bearish MACD cross without defensive structure is a hidden directional bet. Covered call overlay preferred over trim for existing exposure.
| Position | Action |
|---|---|
| Tier 1 initial probe (reduced from trader's 50-65 bps) | 35-40 bps with explicit confirmation filter (either 2-day hold above $89.58 with MACD histogram flattening, OR reclaim of $92.00 on volume >3.5M) |
| Tier 2 zone ($89.50-$90.50) | Maintained unchanged per plan |
| Tier 3 zone ($86.50-$87.50, rising 200 SMA proximity) | Maintained unchanged per plan—higher conviction zone where price meets structural support |
| Existing holders overlay | Deeper-ITM covered call at $90-91 strike (~30 DTE) per 8/20 lesson to convert stagnant tape into carry |
CL at $91.33 is a high-conviction BUY opportunity, not a cautious hold—the market is mispricing a volume-growing, margin-expanding Dividend King with 63 years of consecutive dividend increases, fortress balance sheet (1.30x Net Debt/EBITDA), and a coiled technical setup with asymmetric upside to $94.24–$99+.
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 48.97 | neutral |
| MACD Line | -0.080 | bearish |
| MACD Signal | +0.046 | neutral |
| MACD Histogram | -0.126 | bearish |
| 10 EMA | 91.50 | bearish |
| 50 SMA | 91.63 | bearish |
| 200 SMA | 86.41 | bullish |
| 20 SMA (Bollinger Middle) | 91.91 | neutral |
| Bollinger Upper Band | 94.24 | neutral |
| Bollinger Lower Band | 89.58 | bullish |
| ATR(14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Reclaim of $92.00 on volume >3.5M
Then: Initiate Tier 1 at 35-40 bps
TTM EPS of $2.54 is misleading; normalized EPS is $4.10–$4.11
↩ rebuts: “Bear use of TTM P/E of ~36x to claim rich valuation”
EV: +$8.91 to +$17.67 (from $91.33 to targets of $94.24–$99+, or +9.7% to +19.3% over 4 weeks to 6 months) · concedes: US segment is soft (emerging markets and Europe growing, Hill's growing—this is the diversification moat); Hormuz-related input cost pressure is real (but already priced in at $91, not at $99, and CL delivered +142 bps gross margin expansion despite commodity pressure); SG&A growing 8.5% YoY faster than 4.9% revenue (but CL still expanded gross margin and raised guidance, indicating reinvestment in growth); KO may be winning on relative price momentum (but CL winning on fundamental execution—three quarters of volume growth, raised guidance, expanding margins)
CL is a mature compounder priced for perfection at 22x forward P/E with deteriorating technical momentum, a fragile capital structure masked by buybacks, and macro headwinds that make the risk/reward asymmetrically bearish.
EV: -$5.5% to -10% (risk to $86.41-$89.58 support zones from current $91.33) · concedes: Low-volume bounce (today's 2.58M volume lowest in window) suggests capitulation hasn't fully occurred yet; Dividend yield is above-market at 2.29%; 200 SMA at $86.41 represents a 'last-ditch bull line' if downside materializes
→ vs conservative: The 22x forward P/E is dismissed as 'rich' without accounting for structural acceleration: 142 bps margin expansion and 3 consecutive quarters of positive worldwide organic volume justify the multiple
→ vs conservative: Technical concerns over MACD are overstated—line at -0.08 is negligible, and the pullback came on 60-day low volume, not distribution
→ vs conservative: Iran/Hormuz oil shock fears ignore de-escalation track and the fact that CL already demonstrated 142 bps margin expansion despite firm input costs
→ vs conservative: Rising 200 SMA at $86.41 contradicts waiting for further pullback; waiting is market timing masquerading as discipline
→ vs neutral: Waiting for Hormuz clarity and CPI prints requires timing two binary events while quality compounds at 80% FCF return-to-shareholders; by the time confirmation arrives, entry will be $93-94
→ vs neutral: The 'wait for confirmation' approach fails to capture mean-reversion entry at $91.25 where downside is structurally bounded
| 2.03 |
| neutral |
Support: 91.63 · 91.5 · 89.58 · 86.41 | Resistance: 92.55 · 94.24 · 95.46
CL closed at $91.33 on 2026-08-25, testing its 50 SMA ($91.63) as support in a consolidation phase. The 200 SMA ($86.41) confirms long-term uptrend intact (+5.7% above). RSI midline (48.97), mildly bearish MACD crossover, and compressing ATR (2.03) suggest a coiled-spring pattern with a decision point expected within 3-5 sessions. Key levels: support at $89.58 (lower Bollinger band), resistance at $92.00. Recommendation: HOLD pending directional break.
Market Cap
$72.81B
P/E Ratio (TTM)
35.96x
Forward P/E
22.23x
PEG Ratio
1.75
P/B Ratio
308.5x
Price/Sales (TTM)
~3.46x
Dividend Yield
2.29%
52-Week High
$99.33
52-Week Low
$74.55
50-Day MA
$91.84
200-Day MA
$87.18
Beta
0.327
TTM Revenue
$21.05B
TTM Net Income
$2.04B
TTM EPS
$2.54
Forward EPS
$4.11
Normalized Annual EPS
$4.00–$4.10
Diluted Shares Outstanding
~800M
Q2 2026 Revenue
$5.361B
Q2 2026 Gross Profit
$3.296B
Q2 2026 Gross Margin
61.48%
Q2 2026 Net Income
$693M
Q2 2026 Diluted EPS
$0.86
Q2 2025 Revenue
$5.110B
Q2 2025 Gross Margin
60.06%
Q2 2025 Diluted EPS
$0.91
Revenue YoY Growth (Q2'26 vs Q2'25)
+4.9%
Gross Margin Expansion (YoY)
+142 bps
Operating Margin
20.97%
EBITDA
$4.98B
EBITDA Margin
~23.7%
Gross Margin
~60%
Net Profit Margin (TTM)
9.68%
Net Profit Margin (Normalized)
~12-13%
Return on Assets
15.84%
Return on Equity
267%
SG&A Growth (Q2 2026 vs Q2 2025)
8.5%
Q2 2026 Operating Income
$1.016B
TTM Operating Cash Flow
~$4.45B
Q2 2026 OCF
$995M
Q2 2026 CapEx
$128M
TTM Free Cash Flow
$3.46B
Q2 2026 FCF
$867M
FCF Yield
~4.75%
Annual Dividends Paid
~$1.75B
Annual Share Repurchases
~$1.0B
Total Shareholder Returns
~$2.75B
% FCF Returned to Shareholders
~79%
Debt Paydown
~$0.3B
Retained Cash
~$0.4B
Q4 2025 Non-Recurring Charge
$866M
Total Assets (Q2 2026)
$16.79B
Total Liabilities (Q2 2026)
$16.22B
Stockholders' Equity (Q2 2026)
$236M
Total Debt (Q2 2026)
$7.857B
Cash & Equivalents (Q2 2026)
$1.37B
Net Debt
$6.49B
Treasury Stock (Q2 2026)
$28.93B
Goodwill + Intangibles (Q2 2026)
$4.60B
Net Debt / EBITDA
1.30x
Current Ratio
1.026
Working Capital (Q2 2026)
$160M
Inventory (Q2 2026)
$2.18B
Receivables (Q2 2026)
$1.96B
Debt/Equity (reported)
1388x
Quarterly Dividend Rate
$0.50/share
Strengths
Concerns
Colgate-Palmolive is a mega-cap consumer defensive staple with $72.81B market cap that has delivered 5 consecutive quarters of YoY revenue growth with accelerating top-line momentum. The stock trades near 52-week highs with an elevated forward P/E of 22.23x, though TTM metrics are distorted by an $866M Q4 2025 non-recurring charge that depressed EPS to $2.54 versus normalized $4.10. Strong free cash flow of $3.46B supports shareholder returns of $2.75B annually (79% payout ratio) and 2.29% dividend yield, while the 1.30x Net Debt/EBITDA ratio reflects a healthy balance sheet. Gross margin expanded 142 bps YoY to 61.48%, demonstrating successful pricing actions, though SG&A growth of 8.5% outpacing revenue growth signals near-term margin pressure risk.
Macro: Macro backdrop is characterized by geopolitical shock (Iran/Hormuz disruption driving ~3 mmbpd global inventory draws), a \"stiff Fed\" with 86% probability of no rate cuts in 2026 (deepest policy hold consensus since pre-pandemic), low but creeping recession risk (8% US by end-2026 per Polymarket), sticky moderate inflation (2–4% across major economies), and cross-asset debasement signals (copper ATH, silver >$68). The dominant near-term macro overhang for CL is oil/palm/petrochemical-derived input cost pressure from the Hormuz situation—affecting surfactants, plastics, packaging, and freight costs for the entire household-products complex.